ロード中...
OS2.8 Survival gain and immune response in glioblastoma patients treated with dendritic cell immunotherapy before and during adjuvant temozolomide
BACKGROUND: While immunotherapy is emerging as adjunctive treatment for brain cancer, sensitive method of monitoring the immune response after therapy remains to be established. In the two stage phase I-II study DENDR-I, 24 patients with first diagnosis of glioblastoma (GBM) were treated with dendri...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782518/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|